Amana Cooperative Insurance Co. Announces the Results of the Ordinary General Assembly Meeting (Second Meeting)

Amana Cooperative Insurance Co. shareholders approved the financial statements, board report, and auditor's report for the fiscal year ending December 31, 2025, during an Ordinary General Assembly meeting held on June 25, 2026.
Moore ElSayed Al Ayouty and Crowe were appointed as company auditors for the second, third, and fourth quarters of 2026 and the first quarter of 2027, with fees totaling SAR 512,500 and SAR 525,000 respectively.
Shareholders approved the distribution of SAR 1,324,456 in bonuses to board and subcommittee members for the 2025 fiscal year and ratified the appointment of Mr. Seif Mohammed El-Seif as a non-executive board member.
Related party transactions for 2025 were approved, including a medical claims management contract with GlobeMed Saudi Arabia valued at SAR 14.52 million and insurance contracts with El-Saif Group of Companies valued at SAR 50,000.

Element List	Explanation
Introduction	Amana Cooperative Insurance Co. announces the results of the Ordinary General Assembly meeting (second meeting) due to the lack of a quorum in the first meeting. The second meeting was held one hour after the first meeting, which achieved the necessary quorum for its convening, through modern technology using the Tadawulati system.
City and Location of the General Assembly's Meeting	The company's headquarters are in Riyadh – via modern technology (remotely).
Date of the General Assembly's Meeting	2026-06-25 Corresponding to 1448-01-10
Time of the General Assembly’s Meeting	20:50
Percentage of Attending Shareholders	12.68%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	The following members of the Board of Directors attended the General Assembly meeting: 1- Dr. Abdullah Othman Al-Musa (Chairman of the Board) 2- Mr. Seif Mohammed El-Seif (Vice Chairman of the Board) 3- Mr. Tareq Abdullah Al-Garaawy (Board Member) 4- Mr. Hassan Romaih Al-Zahrani (Board Member) 5- Mr. Khalid Abdulrahman Al-Khudairi (Board Member) 6- Mr. Bashar Talal Kayyali (Board Member) 7- Mr. Pierre Michel Michel Pharaon (Board Member)
Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf	1. Mr. Tareq Abdullah Al-Garaawy (Chairman of the Audit Committee) 2. Mr. Hassan Romaih Al-Zahrani (Chairman of the Risk Management Committee) 3. Mr. Khalid Abdulrahman Al-Khudairi (Chairman of the Nominations and Remuneration Committee) 4. Mr. Bashar Talal Kayyali (Chairman of the Executive Committee) 5. Mr. Tareq Abdullah Al-Garaawy (Chairman of the Investment Committee)
Voting Results on the Items of the General Assembly's Meeting Agenda's	1. The Board of Directors' report for the fiscal year ending December 31, 2025, was reviewed and discussed. 2. The financial statements for the fiscal year ending December 31, 2025, were reviewed and discussed. 3. The company's auditors' report for the fiscal year ending December 31, 2025, was approved after discussion. 4. The Board of Directors was discharged from liability for the fiscal year ending December 31, 2025. 5. The appointment of Moore ElSayed Al Ayouty, with fees of SAR (512,500), and Crowe, with fees of SAR (525,000), as the company's auditors was approved. Their duties include examining, reviewing, and auditing the financial statements for the second, third, and full quarters of fiscal year 2026 and the first quarter of fiscal year 2027. 6. Approval of the disbursement of SAR 1,324,456 as a bonus to the members of the Board of Directors and its subcommittees for the fiscal year ending December 31, 2025. 7. Approval of the transactions and contracts between the company and GlobeMed Saudi Arabia, in which Board members Mr. Naif Faisal Al-Sudairy and Mr. Abdulrahman Abdullah Al-Sakran have an indirect interest. These transactions consist of a medical claims management contract for the company without any special conditions or benefits. The value of these transactions for the year 2025 was SAR 14,521,000. 8. Approval of the transactions and contracts between the company and El-Saif Group of Companies, in which Board member Mr. Naif Faisal Al-Sudairy has an indirect interest. These transactions consist of multiple annual insurance policies and claims paid without any special conditions or benefits. The value of these transactions for the year 2025 was SAR 50,000. 9. Approval of the Board of Directors' decision to appoint Mr. Seif Mohammed El-Seif as a non-executive member of the Board, replacing Mr. Nayef Faisal Al-Sudairy, whose term has expired, effective April 23, 2026, to complete the current term which began on November 9, 2025, and ends on November 8, 2029. 10. Approval of delegating to the Board of Directors the authority of the Ordinary General Assembly to grant the license stipulated in paragraph (1) of Article Seventy-One of the Companies Law, for a period of one year from the date of approval by the General Assembly or until the end of the term of the delegated Board of Directors, whichever is earlier, in accordance with the conditions stipulated in the regulations and procedures issued pursuant to the Companies Law pertaining to listed joint-stock companies.